Evidence map›Paper›PMID 40651833›Full record

ArticleMethods in enzymology2025

Genome mining for the discovery of peptide halogenases and their biochemical characterization.

Nirmal Saha, Vinayak Agarwal

Abstract read
In one paragraph

Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nirmal SahaSchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, GA, United States.
Vinayak AgarwalSchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, GA, United States; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, United States. Electronic address: vagarwal@gatech.edu.

Funding

Halogenation Biochemistry in Human and Environmental HealthR35GM142882 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI AGARWAL, VINAYAK · 2021 to 2025
$1.9M
NIGMS NIH HHS R35 GM142882
6 · The paper itself

Abstract

While halogenation is one of the most versatile C-H functionalization strategy, regiospecific halogenation of peptides and proteins is outside the purview of traditional chemical catalysis. Enzymes that participate in the biosynthesis of ribosomally synthesized and post-translationally modified peptides and proteins can bridge this gap and offer a biocatalytic route for residue-specific incorporation of halogen handles onto amino acid side chains. Protocols described herein provide a guided approach for the discovery of peptide halogenases in the context of natural product biosynthetic gene clusters, and the preliminary reconstitution of their activity using a bacterial heterologous host. Also described are mass spectrometry-based analytical procedures and data analysis workflows that allow for deconvolution of halide specificity and preliminary insights into peptidic natural product biosynthetic schemes. As the available genomic data expands at a rapid rate, the methodology described here will enable the discovery and characterization of new halogenases that can be valuable partners in chemoenzymatic diversification of peptides and proteins.

Indexed as

GenomicsOxidoreductasesPeptidesHalogenationMass SpectrometryMultigene FamilyOxidoreductasesPeptidesGenome miningHalogenaseMass spectrometryRiPPs

Identifiers

PMID40651833
PMCPMC12255868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.